Oncology
Conference Coverage
Liquid Biopsy Has Near-Perfect Accuracy for Early Pancreatic Cancer
Researchers develop signature for pancreatic cancer based on microRNAs and cell-free DNA markers in the blood of patients with the disease.
Conference Coverage
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
Eight of 26 patients with cancer signals detected through MCED had cancer.
From the Journals
New Quality Measure Improves Follow-Up for CRC Screening
Field testing shows that this CRC screening tracker is “feasible, valid, and reliable.”
From the Journals
Eliminating H pylori Lowers CRC Incidence, Mortality Risk
Investigators review CRC incidence and mortality in a nationwide cohort of veterans tested for H pylori.
Latest News
Analysis Finds Low Malignancy Rate in Pediatric Longitudinal Melanonychia
Researchers conducted a systematic review and meta-analysis of the prevalence of clinical and dermoscopic features in 1391 pediatric patients with...
From the Journals
Virtual Reality Brings Relief to Hospitalized Patients With Cancer
Patients were randomized to receive either 10 minutes of immersive VR distraction therapy or 10 minutes of two-dimensional guided imagery...
Feature
Prostate Cancer Tsunami Coming, Experts Caution
Expert suggests approaches for enabling earlier diagnosis of prostate cancer in men in low- to middle-income countries.
Feature
Should Opioids Be Used for Chronic Cancer Pain?
Prescribing strategies are partly driven by peer pressure, new research suggests.
Conference Coverage
Certain Pesticides Linked With Risk for Pancreatic Cancer
Researcher divided the entire French territory into 5529 spatial units and determined the number of pancreatic cancer cases per spatial unit per...
From the Journals
Polygenic Risk Scores Improve Breast Cancer Screening
Researchers examine how well polygenic risk scores predict a person's risk for any breast cancer as well as invasive, in situ, and bilateral at...
Latest News
Immunohistochemistry May Improve Melanoma Diagnosis
The use of immunohistochemistry among Medicare patients with melanoma grew between 2000 and 2017, but substantial regional variations highlight a...